
Precision fermentation is quietly becoming a supply chain strategy for biotech, not just a food tech story
Dr. Dereck Mush, MD, MBAInvestor
A high level strategic forum analyzing the business, investment, and technological forces shaping the global biopharmaceutical industry.
The Financial Times hosts this annual summit in London to analyze commercial strategies in drug development and biotechnology. It features interviews with pharmaceutical chief executives, biotechnology founders, and major healthcare investors. The program focuses on drug pricing, commercialization strategies, regulatory policies, and the integration of artificial intelligence in drug discovery. It is a key event for corporate strategy officers and life science investment managers.
Pharmaceutical executives, biotechnology founders, healthcare investment bankers, and policy analysts attend.
The Financial Times created this event to serve as their flagship executive conference for the life science sector. It has maintained a reputation for high level interviews and rigorous debate on industry economics.
Running this event, or spotted something out of date?

Dr. Dereck Mush, MD, MBA
Dr. Dereck Mush, MD, MBA
Dr. Dereck Mush, MD, MBA
Dr. Dereck Mush, MD, MBAKeep exploring